6 results
The following graph was prepared based on the latest information on Testing for the Diagnosis of
Testing for the Diagnosis ... , don’t bother doing ... viral copies per ml ... upon full sero-conversion ... #HIVAIDS #Testing
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... suspension 4–6 mL ... Systemic antifungals are ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
and molecular diagnostic ... Please refer to the table ... below for TB drug dosing ... Guidelines for dosing ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
of VZV Primary Infection ... health-care provider diagnosis ... or persons who are ... , 2 doses (0.5 mL ... #HIVAIDS #pharmacology
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Skin Disease Classification ... Differential Diagnosis ... fibromyalgia) • Infections ... La, anti-Jo-1, SCL ... Erythematosus #Diagnosis
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
please refer to Table ... 5 for dosing recommendation ... when used with ARV ... opportunistic #infections ... #HIVAIDS #pharmacology